MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-31.99%
↑ 98% vs avg
Percentile
P45
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-1598.56%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -31.99% |
| Q3 2025 | 18.31% |
| Q2 2025 | -42.97% |
| Q1 2025 | 21.32% |
| Q4 2024 | -91.78% |
| Q3 2024 | 9.37% |
| Q2 2024 | -86.58% |
| Q1 2024 | -21.09% |
| Q4 2023 | -33.44% |
| Q3 2023 | 23.92% |
| Q2 2023 | -34.73% |
| Q1 2023 | 22.18% |
| Q4 2022 | -24.00% |
| Q3 2022 | 72.62% |
| Q2 2022 | -140.75% |
| Q1 2022 | -90.36% |
| Q4 2021 | -269.17% |
| Q3 2021 | -32976.30% |
| Q2 2021 | 105.70% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |